PHASTAR Joins Oncology Development Program (ODP2)


PHASTAR, has joined Lean Life Science’s Oncology Development Program (ODP2). The targeted program aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Read more about the program here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.